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OBJECTIVES We investigated the potential association between 514 C3T polymorphism in the
promoter of the hepatic lipase gene (LIPC) and the prevalence of inflammatory cells in the
plaque of patients with severe carotid artery stenosis.
BACKGROUND This common LIPC polymorphism has been related to the presence of an atherogenic
lipoprotein pattern.
METHODS We studied 68 consecutive patients undergoing carotid endarterectomy. The LIPC genotype
was determined by polymerase chain reaction. Endarterectomy specimens were examined by
immunocytochemistry using monoclonal antibodies for smooth muscle cells, macrophages, or
lymphocytes.
RESULTS In 50 of 68 patients who had evidence of previous ipsilateral ischemic events, 36 (72%) were
carriers of the CC genotype, whereas only 14 (28%) were carriers of the CT/TT genotype (p
 0.002). Among the 18 patients without evidence of events, the two genotypes were equally
distributed (9 vs. 9). The low-density lipoprotein (LDL) particles were denser in CC than in
CT/TT genotype carriers (flotation rate: 0.315 0.025 vs. 0.356  0.019, p  0.0005). The
CC genotype was associated with an abundance of macrophages (6.7  3.5 vs. 2.1  2.1
cells/area unit in the CT/TT group, p  0.0005) and a reduced number of smooth muscle
cells (6.9  6.2 vs. 14.5  6.4 in the CT/TT group, p  0.0005) in the plaque. An inverse
relationship was found between LDL buoyancy and the number of macrophages in the plaque
(r  0.639, p  0.0005).
CONCLUSIONS We provide evidence, for the first time, that LIPC promoter 514 C3T polymorphism, by
modulating LDL density, significantly affects the number of macrophages in the plaque and
possibly affects the occurrence of cerebrovascular events in patients with carotid artery
stenosis. (J Am Coll Cardiol 2002;40:1059–66) © 2002 by the American College of
Cardiology Foundation
Ischemic stroke is the third leading cause of death and the
leading cause of disability, with 750,000 new cases of stroke
per year in the U.S. and an annual mortality rate 150,000
(1). According to data from the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET) (2),
atherosclerotic lesions in the extracranial segment of large
arteries account for a substantial proportion of the cerebro-
vascular events observed at five-year follow-up. Similar to
observations made in the coronary arteries (3,4), the pres-
ence of unstable plaque in the carotid arteries has recently
been proposed as the culprit of ischemic stroke (5,6). The
hallmark of unstable plaque is an abundance of macrophages
and other inflammatory cells, with scarce smooth muscle
cells (SMCs) in the fibrous cap region (3,4). These charac-
teristics have been clearly defined in coronary lesions,
although evidence of the presence of such features in
unstable carotid plaque remains confined mainly to ultra-
sound studies and is based on variables of echogenicity or
echolucency (5,6).
Although infection represents a recognized factor in the
pathogenesis of unstable plaque (4), the potential role of
genetic factors is poorly defined. Recent studies have shown
that the common 514 C3T variant in the LIPC pro-
moter is associated with different levels of hepatic lipase
(HL) activity, low-density lipoprotein (LDL) buoyancy,
and high-density lipoprotein-2 (HDL2) cholesterol (7). In
particular, compared with the CT and TT genotypes, the
CC genotype is associated with higher HL activity and
smaller, denser, more atherogenic LDL particles along with
lower HDL cholesterol levels (7). Moreover, in the Familial
Atherosclerosis Treatment Study (FATS), coronary angiog-
raphy after intensive lipid-lowering therapy showed a sig-
nificantly greater improvement in the atherosclerotic lesions
of the CC than the CT and TT genotype carriers (8,9).
We sought to determine whether there is a relationship
between the 514 C3T LIPC promoter variant and the
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presence of unstable plaque in patients enrolled in the
Carotid Atherosclerosis and Restenosis Study (CARS).
This follow-up study of patients who had carotid endarter-
ectomy was aimed at evaluating the molecular and cellular
features of the primary lesions and their potential role in
restenosis and cerebrovascular events (10). Our study pro-
vides evidence for the first time that the CC genotype of the
common 514 C3T variant in the LIPC promoter is
associated with denser LDL, with an increased number of
macrophages in the plaque, and with the rate of cerebro-
vascular events in patients with carotid artery stenosis.
METHODS
Investigations of the LIPC promoter genotype, cell compo-
sition of endarterectomy specimens, and prevalence of
cerebrovascular events, as well as analysis of the data, were
carried out in blinded manner by different researchers.
Blood samples were taken in ethylenediaminetetra-acetic
acid from the antecubital vein before surgery. Samples were
used for routine biochemical assays, and deoxyribonucleic
acid (DNA) extraction for the LIPC promoter and
cholesteryl-ester transfer protein (CETP) genotyping.
Patients. Sixty-eight consecutive patients who had en-
rolled in CARS (10) and had no evidence of present or past
atrial fibrillation were studied. Most of them were recog-
nized as having had ipsilateral cerebrovascular events of
ischemic origin, including transient ischemic attack, stroke,
and minor stroke, before carotid endarterectomy was per-
formed. This was established by the previous medical report
and/or computed tomographic scan. All of the patients had
significant carotid artery narrowing (70%) at angiography.
Lipid and lipoprotein determinations. Plasma, LDL,
HDL cholesterol, triglycerides, apolipoprotein (apo) B, and
apo A-I were measured as previously described (11). Li-
poprotein (a) levels were determined with a monoclonal
antibody-based immunonephelometric assay (12).
DNA extraction and analysis of LIPC promoter and
CETP polymorphism. Deoxyribonucleic acid was ob-
tained from whole blood stocked at 80°C, and analysis
was performed using the Quantum Prep AquaPure
Genomic DNA blood kit (BIO-RAD, Milan, Italy). As
described previously (7), screening for the LIPC 514
C3T polymorphism was carried out by polymerase chain
reaction (PCR) amplification using the primer pair—
forward: 5-CCTACCCCGACCTTTGGCAG-3; and
reverse: 5-GGGGTCCAGGCTTTCTTGG-3.
Amplification was carried out in a 10-l reaction with an
initial denaturation at 94°C for 2 min, followed by 35 cycles
of amplification at 92°C for 15 s, annealing at 64°C for 30 s,
and extension at 72°C for 30 s, with a final extension at
72°C for 7 min.
Five microliters of the PCR product was digested with
the restriction enzyme DraI, followed by electrophoresis on
1% agarose gel.
Screening for the CETP gene TaqIB polymorphism was
carried out by PCR amplification followed by agarose gel
electrophoresis, as previously reported (13).
Density-gradient ultracentrifugation for apo B– contain-
ing lipoproteins. This technique, designed to optimize the
resolution of apo B–containing lipoproteins, is a modifica-
tion of a previous method (14). After creating a discontin-
uous salt density gradient in an ultracentrifuge tube, the
samples were centrifuged at 65,000 rpm for 90 min ( total
t2  2.36  1011) at 10°C in a Sorvall TV-865B vertical
rotor. Thirty-eight 0.45-ml fractions were then collected
from the bottom of the centrifuge tube. Cholesterol was
measured in each fraction. The relative flotation rate (Rf),
which characterizes LDL peak buoyancy, was obtained by
dividing the fraction number containing the LDL choles-
terol peak by the total number of fractions collected.
Immunohistochemistry for cell composition of endarter-
ectomy specimens. The endarterectomy specimens taken
at surgery and suitable for analysis (absence of fragmenta-
tion, fissuring, or loss of structure) were investigated for cell
composition, as previously described (10). In brief, the
specimens were frozen in liquid nitrogen immediately after
they were obtained and stored at 80°C until use. Eight-
micrometer-thick seriate cryosections were processed for
immunohistochemistry using the following monoclonal an-
tibodies: 1) SM-E7, specific to smooth muscle myosin
heavy chains, which recognizes SMCs independently from
their phenotype; 2) HAM56, which recognizes human
macrophages; and 3) CD45RO, which recognizes lympho-
cytes.
Primary antibodies (except for CD45RO) were applied to
freshly cut unfixed cryosections (7 m), as previously
described (10). For the antilymphocyte antibody, cryosec-
tions were first fixed in acetone for 10 min at 20°C and
then washed briefly in phosphate-buffered saline (PBS).
The secondary antibody was anti-mouse immunoglobulin G
(IgG), coupled with horseradish peroxidase diluted in PBS,
bovine serum albumin (1%), and human serum (1%). The
bound IgG was revealed by incubation in the amino-ethyl-
carbazole (Sigma, St. Louis, Missouri) solution. Nuclei were
demonstrated using the bis-benzimide stain (Hoechst
33258, Sigma). Sections were examined with a Zeiss Axio-
plan microscope equipped with a high-resolution telecamera
(Hamamatsu CCD, Shizuoka, Japan), using an 40 Pla-
napo objective lens. Assessment of the different cell types
Abbreviations and Acronyms
ANOVA  analysis of variance
apo  apolipoprotein
CARS  Carotid Atherosclerosis and Restenosis Study
CETP  cholesteryl-ester transfer protein
HDL  high-density lipoprotein
HL  hepatic lipase
LDL  low-density lipoprotein
LIPC  hepatic lipase gene
PCR  polymerase chain reaction
SMC  smooth muscle cells
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was carried out by the same two observers, who were
unaware of the outcome of the ultrasound follow-up studies.
For cell counting, we considered three standard areas (7
 103 m2) of the plaque: the basal, shoulder, and cap
regions. We evaluated the size of each cell population by
assessing, on seriate sections, the number of cells (per area
unit) positive to SM-E7, HAM56, and CD45RO. More-
over, the relative prevalence of each cell type was calculated
as the percentage of positive cells to the total number of
nuclei per area.
To ascertain the reproducibility of the assessment of the
various cell types, three standard sites were selected in eight
randomly chosen endarterectomy specimens: 1) proximal
(cranially); 2) intermediate; and 3) distal (caudally). The
length of specimens ranged from 0.5 to 2.6 cm. In the three
sites, seriate cryosections were cut at 8-m intervals and
processed (immunocytochemistry) for SMCs, macrophages,
and lymphocytes. Variability in cell counts obtained from
the three sites was assessed for each cell type by the use of
analysis of variance (ANOVA) for repeated measurements
within subjects (i.e., specimens) and the coefficient of
variation of the mean difference of repeated measurements.
No difference between repeated assessments of SMCs (F 
2.482, p  0.120), macrophages (F  0.225, p  0.801),
and lymphocytes (F  1.298, p  0.304) was found by
ANOVA. The coefficients of variation were 5.3% for
SMCs, 4.8% for macrophages, and 3.4% for lymphocyte
measurements.
Statistical analysis. Continuous variables were average,
expressed as the mean value  SD and compared by
ANOVA with the Bonferroni correction. The prevalence of
categorical variables was evaluated by two-way contingency
tables, expressed as the percent rate, and compared with the
Pearson chi-square test. The occurrence of a cerebrovascular
event as a categorical variable was placed into a logistic
regression analysis. The number of macrophages per area
unit was also played into a multiple regression analysis
without forcing any item into the equation, obtaining one
multiple correlation coefficient (r). The SYSTAT package
(SPSS Inc., Chicago, Illinois) was used, in which ANOVA
automatically adjusts the significance level according to the
number of variables (i.e., different genotypes) tested.
RESULTS
Among the 68 patients, 45 were carriers of the CC
genotype, 22 of the CT genotype, and one of the TT
genotype of the LIPC promoter (Table 1). The occurrence
of a previous ipsilateral transient ischemic attack or minor
stroke was documented in 50 patients. Among them, 36
(72%) were carriers of the CC genotype, whereas only 14
(28%) were carriers of the CT genotype (p  0.002).
Among the 18 patients without evidence of previous events,
nine were carriers of the CC, eight of the CT, and one of
the TT genotype. Values of blood pressure and plasma
lipids and the prevalence of risk factors for atherosclerosis
Table 1. General Data According to Hepatic Lipase Genotype
CC (n  45) CT/TT (n  23) p Value by ANOVA
Males 37 (82%) 19 (82%) NS (0.968)
Age (yrs) 67.1  8.6 67.8  8.1 NS (0.735)
Body mass index (kg/m2) 25.3  2.3 24.3  3.2 NS (0.169)
Systolic BP (mm Hg) 148  17 147  18 NS (0.834)
Diastolic BP (mm Hg) 84  9 84  10 NS (0.721)
Glucose (mg/dl) 120  51 110  29 NS (0.386)
Cholesterol (mg/dl) 232  41 228  34 NS (0.736)
HDL cholesterol (mg/dl) 51  13 55  13 NS (0.229)
TC/HDL cholesterol 4.8  1.6 4.4  1.3 NS (0.362)
LDL cholesterol (mg/dl) 151  38 148  32 NS (0.727)
Triglycerides (mg/dl) 149  68 136  54 NS (0.410)
Apo A (mg/dl) 162  23 164  25 NS (0.765)
Apo B (mg/dl) 150  29 146  29 NS (0.517)
Lipoprotein (a) (mg/dl) 21  20 24  24 NS (0.680)
Fibrinogen (mg/dl) 291  77 305  53 NS (0.435)
Plasminogen (mg/dl) 12.3  1.5 13.0  5.0 NS (0.445)
Homocysteine (mg/dl) 15.2  5.7 16.6  8.0 NS (0.494)
LDL density (rate of flotation) 0.315  0.025 0.356  0.019 0.0005
CETP NS (0.900)
B1B1 17 (40%) 9 (39%)
B1B2 20 (48%) 12 (52%)
B2B2 5 (12%) 2 (9%)
CV events (n  50) 36 (72%) 14 (28%) 0.002*
No CV events (n  18) 9 (50%) 9 (50%) NS (1.0)†
*Compared by Pearson’s chi-square test considering population with cerebrovascular (CV) events only. †Compared by Pearson’s
chi-square test considering population free of CV events only. Data are presented as the number (%) of patients or mean value
 SD. Pearson’s chi-square test was used for categorical variables, and analysis of variance (ANOVA) with the Bonferroni-
corrected post-hoc test was used for continuous variables.
Apo  apolipoprotein; BP  blood pressure; CETP  cholesteryl-ester transfer protein; HDL and LDL  high- and
low-density lipoprotein, respectively; NS  nonsignificant; TC  total cholesterol.
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were similar between the two genotype groups, but the
LDL buoyancy (Rf) was significantly lower in the CC group
than in the CT/TT group (Table 1). The distribution of the
different CETP genotypes was similar between the CC and
CT/TT genotype groups (Table 1), as well as in patients
who had events compared with those who did not (data not
shown).
When patients were studied according to the CETP
genotype (B1B1, B1B2, and B2B2), no difference in the lipid
profile and cell composition of the plaque was found among
the three groups (not shown).
The tissue retrieved at the endarterectomy procedure was
suitable for the blind analysis of the cell composition in 45
cases: twenty-seven of these had the CC, and 18 had the
CT genotype (Table 2). The CC genotype was associated
with an increased number of macrophages (6.7 3.5 vs. 2.1
 2.1 cells per area unit in the CT/TT group, p  0.0005)
and a reduced number of SMCs (6.9  6.2 vs. 14.5  6.4
in the CT/TT group, p  0.0005) in the plaque (Table 2,
Fig. 1). The same pattern of cell composition was present in
the cap region of the plaque (Table 2). A strong, inverse
relationship was found between LDL buoyancy and the
number of macrophages in the plaque (r  0.639, p 
0.0005). After adjusting for LDL density, the difference
between the HL genotype groups in the number of macro-
phages in the plaque was no longer significant. Moreover, it
turned out that in patients with previous cerebrovascular
events, the inverse relationship between LDL buoyancy and
macrophages was present in the CC but not in the CT/TT
genotype carriers (Fig. 2). The amount of lymphocytes was
similar between the two genotype groups (Table 2). Medial
layers underlying the plaque (Fig. 1) were present in 50%
of specimens. Those specimens from patients carrying the
CC genotype showed a slightly higher number of SMCs, as
compared with specimens from patients with the CT/TT
genotype (Table 2).
The multiple regression analysis showed that none of the
quantitative lipid variables (i.e., LDL and HDL cholesterol,
lipoprotein [a], triglycerides) was associated with the num-
ber of macrophages in the plaque (Table 3). Instead, a
strong inverse association was found with LIPC polymor-
phism (model 5, p  0.001), which accounted for 32% of
the variance in the number of macrophages in the plaque.
When LDL buoyancy was added into the multivariate
model, it was the only variable associated with the number
of macrophages (model 6, p  0.014), whereas LIPC
polymorphism was no longer a significant factor. Moreover,
the final model explained 50% of the variance in the
number of plaque macrophages (model 6). The logistic
regression analysis (Table 4) showed that LIPC polymor-
phism was significantly associated with cerebrovascular
events (model 5, p  0.027) and remained so even when
LDL buoyancy was accounted for (model 6, p  0.031).
However, the macrophages were the only factor significantly
linked to the occurrence of cerebrovascular events when
added to the final model (model 8, p  0.015), which
accounted for 36% of the variance of events in this group.
Exclusion or inclusion of the only patient carrying the TT
genotype did not affect the results. Finally, probably due to
the limited range in the degree of carotid stenosis (70% to
99%), there was no relationship between HL genotype and
the severity of carotid artery narrowing at angiography.
DISCUSSION
This study provides novel evidence that an association exists
between the CC genotype of the LIPC promoter and an
abundance of macrophages in atherosclerotic lesions. This
association is likely due to the presence of denser, more
atherogenic LDL in carriers of the CC genotype, who also
showed an increased susceptibility to cerebrovascular events.
Previous studies in patients with coronary artery disease
receiving intensive cholesterol-lowering therapy showed
that LDL density is inversely related to the progression of
coronary artery lesions (15), but information on the LIPC
genotype and the cell composition of atherosclerotic lesions
was not available.
Hepatic lipase polymorphism and plaque composition.
The 514 C3T polymorphism in the promoter region of
the HL gene is related to high HL activity, small and dense
LDL particles, and low HDL2 cholesterol (7,16). Subjects
with small, dense LDL particles are at higher risk of
coronary artery disease than subjects with large, buoyant
LDL (17,18). Potential mechanisms underlying this in-
creased atherogenicity of small LDL particles include an
increased rate of LDL oxidation (19). This leads to a higher
tendency of oxidized LDL to become entrapped in the
subintima (20), where they increase the expression of
chemoattractants (21), inflammatory (22), and adhesion
molecules (23) by endothelial and SMCs. Moreover, these
lipoproteins induce endothelial dysfunction independent of
HDL and LDL cholesterol and triglyceride concentrations
(24) and are associated with increased thickness of the
carotid intima-media in healthy men (25).
Hepatic lipase activity is a key determinant of LDL size,
accounting for 30% to 45% of LDL size and density
Table 2. Cell Composition* of Carotid Endarterectomy
Specimens and Hepatic Lipase Genotype
CC CT/TT p Value
Atherosclerotic plaque (n  27) (n  18)
SMCs† 6.9  6.2 14.5  6.4 0.0005
Macrophages 6.7  3.5 2.1  2.1 0.0005
Lymphocytes 6.1  3.4 6.4  6.2 NS
Cap region (n  25) (n  18)
SMCs† 5.5  5.2 14.9  9.9 0.0005
Macrophages‡ 7.0  4.5 2.3  3.5 0.001
Lymphocytes§ 9.2  8.6 14.0  11.3 NS
Tunica media (n  15) (n  14)
SMCs† 19.8  6.1 15.4  5.1 0.044
*Number of cells per area unit positive to the various monoclonal antibodies. †Smooth
muscle cells (SMCs) recognized by SM-E7. ‡Recognized by HAM56. §Recognized
by CD45RO. Analysis of variance with the Bonferroni-corrected post-hoc test was
used. Data are presented as the mean value  SD.
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variability (12,26). In addition, serum triglyceride levels and
CETP activity are other regulatory factors (27). Triglyceride
levels, however, were similar between the two groups in our
series, and this is likely to have blunted the potential role of
CETP in determining LDL particle size. The CETP
genotypes were not associated with either the number of
plaque macrophages or cerebrovascular risk in these pa-
tients, as confirmed by the results of the multivariate
analyses. Other risk factors were similar between the two
LIPC genotype groups (Table 1) and were not significantly
associated with the occurrence of events and the cellular
composition of the lesions (Tables 3 and 4).
The abundance of macrophages and the relative scarcity
of SMCs in the plaque and fibrous cap of patients with the
CC genotype versus the CT/TT genotype (Table 2) repre-
sent a novel finding. Carriers of the CC genotype had
significantly denser LDL particles than did patients with
the CT/TT genotype, confirming previous observations
(7,28) where HL gene polymorphism accounted for 20% to
32% of the variance in HL levels. In the CC carriers, LDL
density was strongly associated with increased plaque mac-
rophages (Fig. 2), providing a potential pathophysiologic
explanation for the association between HL genotype and
plaque cellular composition—namely, macrophage abun-
dance (Table 3). Although our study does not provide direct
evidence of a causative role of LDL density in determining
plaque cellular composition, available evidence supports a
pathophysiologic link between small, dense LDL and
plaque cellular composition. In particular, dense LDL
particles can more easily permeate the endothelium, reach-
ing the subendothelial space (29), where they are more
susceptible to oxidation, as demonstrated by in vitro studies
(30). Oxidized LDL affects the structure of proteoglycans
produced by SMCs, increasing their affinity for both native
and oxidized LDL (20). In addition, oxidized LDL in-
creases the expression of chemoattractants such as
Figure 1. Representative micrographs of carotid endarterectomy specimens form CC (A and C) and CT (B and D) genotype carriers. A prevalence of
macrophages (stained with HAM56) was found in specimens obtained from the CC carriers, whereas smooth muscle cells (SMCs) (stained with SM-E7)
were more numerous in specimens obtained from the CT carriers. The insets in B and C display, at high magnification, the staining of plaque areas for
macrophages and SMCs, respectively. The number of cells per area unit was assessed by computerized image analysis (see Methods and ref. 10). m tunica
media; pl  atherosclerotic plaque. Bar  80 m. Magnification 20 Planapo objective.
1063JACC Vol. 40, No. 6, 2002 Faggin et al.
September 18, 2002:1059–66 Hepatic Lipase Genotype and Unstable Carotid Plaque
interleukin-8 (21), inflammatory molecules such as matrix
metalloproteinase-1 (22), and adhesion molecules such as
monocyte hemoattractant protein-1, by endothelial and
SMCs (23). In agreement with these observations, in a
subset of our specimens, in subjects with the CC genotype,
we found significantly increased expression of acidic fibro-
blast growth factor, a macrophage-related factor that is
induced by oxidized LDL as well (31) (unpublished data).
By these mechanisms, small, dense, oxidized LDL may play
a role in plaque cellular composition, matrix remodeling,
plaque destabilization, and clinical events.
Accordingly, when LDL density was included in the
multivariate analysis, the LIPC polymorphism was no
longer a predictor of the number of macrophages in the
plaque. Thus, the association between LIPC polymorphism
and the number of macrophages appears to be, at least
partly, accounted for by the effect of the former on LDL
density.
Although total HDL cholesterol was not associated with
the abundance of macrophages (Table 3) in the plaque, we
cannot rule out a possible additional effect of HDL sub-
populations on plaque composition, specifically HDL2 par-
ticles, which may be clinically relevant, because the HL
polymorphism also significantly affects HDL2 cholesterol
levels.
Cerebrovascular events and plaque composition. The
number of macrophages in the plaque predicted cerebrovas-
cular events in our study group (Table 4). It is worthwhile to
note that the LIPC polymorphism remained associated with
cerebrovascular events even after adding LDL density to the
model. This finding suggests that HL, which is significantly
controlled by LIPC polymorphism (7,9), affects both plaque
composition (Table 3, model 6) and cerebrovascular events
(Table 4, models 6 and 7) by additional mechanism(s). This
hypothesis is supported by recent evidence of a role of HL
in atherogenic lipoprotein metabolism, independent of its
lipolytic activity (32).
Lymphocytes were equally distributed in the lesions from
the two main genotype groups, and this may indicate that
LIPC polymorphism exerts a selective action on macro-
phages. In the CC genotype carriers, a reduced number of
SMCs was found in the atherosclerotic lesions. Instead, the
SMCs were abundant in the media underlying the lesions
from patients of this group. On the whole, this outlines a
typical feature of carotid lesions found in CARS subjects
(10), whose lipid-laden lesions with a predominant inflam-
matory component showed a well-preserved tunica media,
as compared with subjects whose lesions were mainly
composed of SMCs and whose media was relatively poor of
cells. This is probably part of a complex process that
Figure 2. Relationship between low-density lipoprotein (LDL) density and number of macrophages in the atherosclerotic plaque. The analysis was carried
out in patients from the two genotype groups who had cerebrovascular events. n/au  cells/area unit.
Table 3. Multiple Regression Models for Factors Potentially Linked to the Number of Macrophages per Area Unit in the Plaque
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
 p  p  p  p  p  p
Triglycerides 0.049 0.749 0.197 0.229 0.226 0.189 0.259 0.137 0.190 0.183 0.266 0.126
LDL cholesterol 0.085 0.600 0.077 0.641 0.102 0.536 0.067 0.618 0.121 0.359
HDL cholesterol 0.102 0.541 0.119 0.474 0.059 0.662 0.017 0.894
Lipoprotein (a) 0.189 0.241 0.142 0.280 0.119 0.347
LIPC polymorphism 0.585 <0.001 0.288 0.067
LDL-Rf 0.446 0.014
Adjusted R2 value 0.002 0.037 0.046 0.081 0.404 0.502
All models include as independent variables: CETP polymorphism, fibrinogen, plasminogen, homocysteine, and glucose; none were significantly associated with the number of
macrophages in the plaque. Beta values are expressed as standardized coefficients. Bold numbers indicate significance.
HDL  high-density lipoprotein; LDL  low-density lipoprotein; LIPC  hepatic lipase gene promoter (coded as follows: CO  0; CT  1; TT  2); LDL-Rf 
low-density lipoprotein relative flotation rate.
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includes the activation of adventitial fibroblasts to myofi-
broblasts and subsequent translocation of these cells to the
media, perhaps to replace medial SMCs that have migrated
to form the intimal lesion (33). Unfortunately, information
on parallel changes in cell composition of the adventitial
layer was not available under these experimental conditions.
Another relative limitation of this study is related to the
sample size of our study group. The size appears to be
appropriate for the detailed investigation needed to define
the pathophysiologic mechanism(s) accounting for genetic
modulation of unstable carotid plaque. However, it may not
be suitable for a compelling study of genetic association.
Conclusions and clinical implications. We have provided
some novel pathophysiologic steps of a complex mechanism
linking LIPC polymorphism, carotid plaque composition,
and cerebrovascular events in patients with severe carotid
artery stenosis. These findings may have potentially relevant
clinical implications by disclosing the value of future,
population-based studies of genetic association, which are
needed to confirm the relevance of LIPC polymorphism as
a marker to detect subjects at high risk of cerebrovascular
events who are potential candidates for intensive primary
care.
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